Objectives
Phosphodiesterase 5 inhibitors (PDE5i) are considered among the first-line treatment options for erectile dysfunction (ED). Their impact in terms of long-term psychological well-being has been scantly analysed. This retrospective cross-sectional study aimed to investigate PDE5i...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.